「Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy」の関連論文
-
Molecular design of dendrimers with anionic terminal groups for delivery to various lymph node-resident cells
-
Activation of BAX and BAK is an attractive combination therapy in melanoma
-
Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice
-
JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Tenascin C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
Construction of a single-cell atlas of non-hematopoietic cells in human lymph nodes and lymphoma for dissecting stromal remodeling
-
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1
-
Clinical efficacy of the combined treatment of anti-PD-L1 rat-bovine chimeric antibody with a COX-2 inhibitor in calves infected with Mycoplasma bovis
-
Survival Analyses Based on Tumor Microenvironment Profile in Endometrial Carcinoma
-
Finding potential synergistic drugs to reduce chemo-resistance for the treatment of highly malignant tumors in female
-
Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
Project 1 Analyzing Tumor Microenvironment and Exploiting its Characteristics in Search of Optimizing Cancer Therapy Including Neutron Capture Therapy (R2P1)
-
Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress
-
Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress
-
Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis
-
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
-
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
-
Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs
-
Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression
-
2-nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche (本文)
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer
-
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
-
Impaired CD4⁺ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination
-
Interleukin (IL)-17A is a potent prognostic factor associated with intratumoral neutrophil infiltration and C-X-C chemokine motif ligand 1 in triple-negative breast cancer
-
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Mechanisms of HIV-induced peripheral neuropathic pain by focusing on Schwann cell-macrophage interaction
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Neutrophil Extracellular Traps Promote Metastases of Colorectal Cancers through Activation of ERK Signaling by Releasing Neutrophil Elastase
-
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
-
The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
-
Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor α
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
Non-Genetic Cell-Surface Modification with a Self-Assembling Molecular Glue
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients